Amyris and Squalan Natural Health Enter Emollient Deal

Amyris and Squalan Natural Health B.V. have entered into agreements for the production and marketing of Neossance Squalane-based skin care and personal care products.

The emollient, produced from plant sugars, will be applied to products sold to retailers and consumers, primarily in the European Union.

Neossance Squalane has moisturizing properties that reportedly boost skin texture, smoothness and silkiness, without a greasy feel.

Under terms of the deal, Squalan will continue to be managed by founders Leslie van der Meijden and Monique Hugen, Amyris is investing in the company, will have an option to acquire an ownership stake and have the right to appoint a member of Squalan’s board of directors.

More in Regulatory